Interim vs End-of-Treatment — PET Scanning Explained

An interim PET scan is done mid-treatment to check whether treatment is working as expected, and the result directly shapes the next treatment decision. An end-of-treatment PET scan, done after all cycles are complete, assesses what the full course achieved. They use the same equipment but answer different questions at different moments. Not every patient needs both — whether you do depends on your cancer type and the protocol your oncologist is following, which should be explained to you before treatment starts.

The timing is set by your treatment protocol, not by the calendar. For lymphomas, the scan is typically done after a specific number of cycles at the mid-point of the course. The cycle number matters more than the number of weeks that have passed. Do not book the scan without confirming the exact cycle number with your team — an early scan may give a result that does not reflect how the treatment has actually performed, and a late one loses the value of a mid-course decision.

Complete metabolic response means no area of the body is showing the level of glucose uptake that would indicate active cancer, at the sensitivity of the scan. It is the most favourable end-of-treatment PET result. It does not mean the cancer cannot return, and it does not on its own determine your surveillance plan — your oncologist will explain what the result means for your situation and what the follow-up schedule will be. Ask for the clinical meaning in plain language, not just the radiological term.

PET-CT pricing varies by city and imaging centre, and any figure from a website becomes outdated quickly. At CION, PET-CT is coordinated with partner imaging centres; ask your care team to confirm the current rate for the centre your scan will be done at. If your treatment is covered by Aarogyasri, PMJAY, or a private insurer, ask whether PET-CT is included in your coverage and whether there is a per-year limit on scans — the team at your CION centre can help you check before the scan is booked.

A result that shows residual activity at the interim point will usually prompt a discussion about changing treatment — intensifying the regimen, switching to a different one, or considering other options. This is exactly what interim PET is designed for: catching a sub-optimal response early enough to act on it. Ask your oncologist to walk through the options with you, including what each is expected to achieve and what the risks are. An interim result showing residual activity is a decision point, not a final answer about your prognosis.

Tell your team immediately if you feel worse — that information matters regardless of whether a scan is the right response. Whether an unscheduled scan is useful depends on what is being assessed and whether the result at that point in your treatment would actually change a clinical decision. A PET done outside protocol timing can be harder to interpret and may raise concerns about findings that are expected and harmless at that stage. Your oncologist will advise whether an urgent scan is indicated or whether a clinical review and blood tests are the better first step.